May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Topical Application for Corneal Regression and Haze in an in vitro Model
Author Affiliations & Notes
  • T. Ide
    Ophthalmology, Osaka Univ Medical School, Suita, Japan
  • K. Nishida
    Ophthalmology, Tohoku Univ Medical School, Sendai, Japan
  • M. Yamato
    Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan
  • Y. Hori
    Ophthalmology, Osaka Univ Medical School, Suita, Japan
  • N. Maeda
    Ophthalmology, Osaka Univ Medical School, Suita, Japan
  • T. Okano
    Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan
  • Y. Tano
    Ophthalmology, Osaka Univ Medical School, Suita, Japan
  • Footnotes
    Commercial Relationships  T. Ide, None; K. Nishida, None; M. Yamato, None; Y. Hori, None; N. Maeda, None; T. Okano, None; Y. Tano, None.
  • Footnotes
    Support  Grant(15390530) from the Ministry of Education, Culture, Sports, Science and Technology, Japan
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2727. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Ide, K. Nishida, M. Yamato, Y. Hori, N. Maeda, T. Okano, Y. Tano; Topical Application for Corneal Regression and Haze in an in vitro Model . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2727.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : PRK and LASIK have become popular methods for the correction of refractive errors. However, regression and haze remain serious post–operative complications. Aside form steroids, beta blockers were reported to prevent or reverse haze and regression in clinical studies, but there have been no experimental reports. We therefore examined the effects of beta blockers on keratocytes, and we performed basic research on regression and haze using an in vitro model.

Methods: : For gel contraction assay, keratocytes were cultured in a collagen gel matrix to set keratocytes more in–vivo–like state. To observe cell morphology, cells were seeded into the gels or into the well of 12 well culture plates. To analyze myofibroblast markers, collagen type III (Col 3) and alpha smooth muscle actin (αSMA) mRNA expression indices were assessed by real–time quantitative RT–PCR. In each experimental system, a defined volume of various eye drops was added to the medium.

Results: : In addition to beta blockers, various IOP–reducing agents and other eye drops frequently used after refractive surgery were applied for screening and comparison in this study. Among the examined medications, carteolol hydrochloride (Mikelan®) and diclofenac sodium (Diclod®) inhibited gel contraction significantly, but timolol maleate (Timoptol®) did not. Keratocytes treated by Mikelan® became more polygonal on the well and more spherical within the gels, whereas keratocytes treated by other agents or controls showed fibroblastic appearance. Col 3 mRNA expression levels in cells treated with non–selective beta blockers (Timoptol® and Mikelan®) were significantly lower than the expression level when treated with other drugs. In contrast, αSMA expression level did not show a significant difference.

Conclusions: : It is worth trying these beta blockers and Diclod® clinically, in particular Mikelan®, to prevent regression and corneal haze after refractive surgeries. If successful, these pharmacological effects can likely be applied not only to post–refractive surgeries, but also to situations in which activated fibroblasts play a role.

Keywords: cornea: stroma and keratocytes • refractive surgery: LASIK • refractive surgery: comparative studies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×